Glaukos Corp share price logo

Glaukos Corp Share Price

NYSE: GKOS

Mid Cap

$82.29

+1.65

(+2.05%)

as on

Glaukos Corp Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $80.85
    $83.26
    downward going graph

    1.75%

    Downside

    1.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $77.1
    $163.71
    downward going graph

    6.30%

    Downside

    98.94%

    Upside

    downward going graph

Glaukos Corp share price movements today

Previous Close
$80.64
Open
$81.03
Volume
533.4K
Day's Low - High
$80.85 - $83.26
52 Week Low - High
$77.1 - $163.71

Glaukos Corp Historical Returns

1 Month Return
-10.26 %
3 Month Return
-19.47 %
1 Year Return
-35.11 %
3 Year Return
+ 39.83 %
5 Year Return
+ 63.94 %

Glaukos Corp Stock Fundamentals & Key Indicators

Check Glaukos Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.7B

EPS (TTM)

-0.895

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

18.96%

PE Ratio (TTM)

-45.94

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

1.64

EBITDA

-62.2M

Revenue (TTM)

433.0M

Profit Margin

-21.43%

Return On Equity TTM

82374500.00%

Glaukos Corp Stock Valuation

Track how Glaukos Corp P/E has moved over time to understand its valuation trends.

Glaukos Corp in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 16, 2025

Today (-45.94x)

September 16, 2025

Industry (10.13x)

September 16, 2025

Highest (0.00x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: -45.94x

Glaukos Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glaukos Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$4.7B63.94%-45.94-21.43%
BUY$152.2B148.49%60.913.55%
BUY$146.6B74.74%50.7612.25%
BUY$232.8B24.25%16.7732.43%
BUY$120.6B-13.08%25.9513.63%

Stock Returns calculator for Glaukos Corp Stock including INR - Dollar returns

The Glaukos Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Glaukos Corp investment value today

Current value as on today

₹71,086

Returns

₹28,914

(-28.91%)

Returns from Glaukos Corp Stock

₹33,781 (-33.78%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Glaukos Corp Stock

Based on 20 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for Glaukos Corp. Average target price of $122.46

Glaukos Corp Share Price Target

Get share price movements and forecasts by analysts on Glaukos Corp.

What analysts predicted

32.8%UPSIDE

Target Price

$122.46

Current Price

$82.29

Analyzed by

20 Analysts

Target

$122.46

Glaukos Corp target price $122.46, a slight upside of 32.8% compared to current price of $82.29. According to 20 analysts rating.

Glaukos Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
73
80
78
82
85
95
96
105
106
124
Gross Profit
55
60
59
63
65
73
74
76
82
97
Operating Income
-32
-29
-28
-38
-27
-27
-24
-28
-20
-22
EBITDA
-21
-19
-17
-23
-27
-29
-10
-22
-20
-8
Interest Expense
3
3
3
3
3
3
1
1
1
1
Depreciation
9
7
11
9
9
7
12
9
9
9
Income Before Tax
-34
-32
-30
-36
-40
-50
-21
-33
-17
-19
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-34
-32
-30
-36
-40
-50
-21
-33
-18
-19
Net Profit Margin
-46.86%
-40.81%
-39.01%
-44.65%
-47.70%
-52.82%
-22.15%
-31.83%
-17.01%
-15.84%

Glaukos Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
71
114
159
181
236
224
294
282
314
383
Gross Profit
58
98
138
156
198
133
227
213
239
289
Operating Income
-10
4
-2
-13
-50
-123
-62
-102
-128
-122
EBITDA
-32
8
5
-6
-37
-83
-1
-48
-82
-77
Interest Expense
1
0
0
-
2
14
13
13
13
10
Depreciation
-
-
5
6
9
34
34
35
37
39
Income Before Tax
-38
4
0
-12
-50
-132
-49
-98
-133
-145
Income Tax Expense
0
0
0
0
-65
-11
0
0
0
0
Net Income
-37
4
0
-12
15
-120
-49
-99
-134
-146
Net Profit Margin
-51.94%
3.95%
-0.06%
-7.14%
6.51%
-53.50%
-16.87%
-35.07%
-42.79%
-38.17%

Glaukos Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-32
-30
-36
-40
-50
-21
-33
-18
-19
Operating Cash Flow
-8
-8
-10
-33
-18
-9
0
-18
6
Investing Cash Flow
25
14
-12
-29
34
30
11
-36
-20
Financing Cash Flow
0
7
7
13
8
9
60
1
2
Change in Cash
17
14
-15
-50
25
32
69
-55
-14

Glaukos Corp Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
4
0
-12
15
-120
-49
-99
-134
-146
Operating Cash Flow
12
25
18
0
-22
24
-33
-57
-61
Investing Cash Flow
-26
-11
-26
43
-205
-58
44
14
47
Financing Cash Flow
-1
4
21
-9
262
39
6
15
91
Change in Cash
-15
18
14
33
34
3
16
-27
75

Global Institutional Holdings in Glaukos Corp

Funds
Holdings
BlackRock Inc
14.92%
FMR Inc
11.4%
Vanguard Group Inc
10.4%
Wellington Management Company LLP
3.99%
State Street Corp
3.46%

Insights on Glaukos Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 8 quarters, 78.04M → 124.12M (in $), with an average increase of 6.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 21.0% return, outperforming this stock by 54.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 139.5% return, outperforming this stock by 99.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -18.14M → -19.65M (in $), with an average decrease of 8.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GKOS stock has moved down by -7.9%

About Glaukos Corp

glaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. glaukos has pioneered micro-invasive glaucoma surgery, or migs, to revolutionize the traditional glaucoma treatment and management paradigm. the company launched the istent trabecular micro-bypass stent, its first migs device, in the united states in 2012. glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. glaukos believes the istent is the smallest medical device ever approved by the food and drug administration, or fda, measuring 1.0 mm long and 0.33 mm wide. in june 2015, the company completed an initial public offering and its shares are now traded on the new york stock exchange unde
OrganisationGlaukos Corp
HeadquartersOne Glaukos Way, Aliso Viejo, CA, United States, 92656
IndustryHealth Technology
CEOMr. Thomas William Burns
E-voting on sharesClick here to vote

Key Management of Glaukos Corp

Name

Title

Mr. Thomas William Burns

Chairman & CEO

Mr. Joseph E. Gilliam

President & COO

Mr. Alex R. Thurman

Senior VP & CFO

Mr. Robert L. Davis J.D.

Senior VP, General Counsel & Business Development

Ms. Diana A. Scherer

VP of Compliance & Deputy General Counsel

Ms. Jane E. Rady

Senior Vice President of Corporate Strategy & Business Development

Dr. Tomas Navratil Ph.D.

Chief Development Officer

Mr. Christopher William Lewis

Vice President of Investor Relations & Corporate Affairs

Ms. Michele M. Allegretto

Senior Vice President of Human Resources

Mr. L. Jay Katz FACS, M.D.

Chief Medical Officer

FAQs

What is Glaukos Corp share price today?

Glaukos Corp share price today is $82.29 as on at the close of the market. Glaukos Corp share today touched a day high of $83.26 and a low of $80.85.

What is the 52 week high and 52 week low for Glaukos Corp share?

Glaukos Corp share touched a 52 week high of $163.71 on and a 52 week low of $77.1 on . Glaukos Corp stock price today i.e. is closed at $82.29,which is 49.73% down from its 52 week high and 6.73% up from its 52 week low.

What is Glaukos Corp's market capitalisation today?

Glaukos Corp market capitalisation is $0.00T as on .

How to invest in Glaukos Corp Stock (GKOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Glaukos Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Glaukos Corp Shares that will get you 0.0182 shares as per Glaukos Corp share price of $82.29 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Glaukos Corp Stock (GKOS) from India?

Indian investors can start investing in Glaukos Corp (GKOS) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Glaukos Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Glaukos Corp share’s latest price of $82.29 as on September 17, 2025 at 1:29 am IST, you will get 0.1215 shares of Glaukos Corp. Learn more about fractional shares .

What are the returns that Glaukos Corp has given to Indian investors in the last 5 years?

Glaukos Corp stock has given 63.94% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?